February 24, 2026 Gaylussacin Inhibits COPD Progression by Targeting CK2-Mediated CTCF Activation in Macrophages
February 23, 2026 Professor Rodgers Wins NSW Cardiovascular Research Excellence Award | 2025 Ministerial Award